 Myocardial Reperfusion Injury
"Myocardial Reperfusion Injury" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Damage to the MYOCARDIUM resulting from MYOCARDIAL REPERFUSION (restoration of blood flow to ischemic areas of the HEART.) Reperfusion takes place when there is spontaneous thrombolysis, THROMBOLYTIC THERAPY, collateral flow from other coronary vascular beds, or reversal of vasospasm.
| Descriptor ID |
D015428
|
| MeSH Number(s) |
C14.280.238.615 C14.280.647.625 C14.907.585.625 C14.907.725.600 C23.550.767.877.500
|
| Concept/Terms |
Myocardial Reperfusion Injury- Myocardial Reperfusion Injury
- Injuries, Myocardial Reperfusion
- Myocardial Reperfusion Injuries
- Reperfusion Injuries, Myocardial
- Myocardial Ischemic Reperfusion Injury
- Reperfusion Injury, Myocardial
- Injury, Myocardial Reperfusion
|
Below are MeSH descriptors whose meaning is more general than "Myocardial Reperfusion Injury".
Below are MeSH descriptors whose meaning is more specific than "Myocardial Reperfusion Injury".
This graph shows the total number of publications written about "Myocardial Reperfusion Injury" by people in this website by year, and whether "Myocardial Reperfusion Injury" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1991 | 3 | 2 | 5 | | 1992 | 3 | 0 | 3 | | 1993 | 4 | 0 | 4 | | 1994 | 2 | 0 | 2 | | 1995 | 1 | 0 | 1 | | 1996 | 5 | 0 | 5 | | 1997 | 5 | 0 | 5 | | 1998 | 4 | 1 | 5 | | 1999 | 3 | 2 | 5 | | 2000 | 2 | 3 | 5 | | 2001 | 1 | 1 | 2 | | 2002 | 0 | 4 | 4 | | 2003 | 4 | 0 | 4 | | 2004 | 3 | 0 | 3 | | 2005 | 2 | 0 | 2 | | 2006 | 1 | 1 | 2 | | 2007 | 6 | 0 | 6 | | 2008 | 6 | 0 | 6 | | 2009 | 1 | 1 | 2 | | 2010 | 1 | 0 | 1 | | 2011 | 5 | 1 | 6 | | 2012 | 3 | 0 | 3 | | 2013 | 5 | 2 | 7 | | 2014 | 4 | 0 | 4 | | 2015 | 4 | 1 | 5 | | 2016 | 6 | 1 | 7 | | 2017 | 3 | 0 | 3 | | 2018 | 1 | 0 | 1 | | 2020 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Myocardial Reperfusion Injury" by people in Profiles.
-
Duerr GD, Heine A, Hamiko M, Zimmer S, Luetkens JA, Nattermann J, Rieke G, Isaak A, Jehle J, Held SAE, Wasmuth JC, Wittmann M, Strassburg CP, Brossart P, Coburn M, Treede H, Nickenig G, Kurts C, Velten M. Parameters predicting COVID-19-induced myocardial injury and mortality. Life Sci. 2020 Nov 01; 260:118400.
-
Lee JW, Koeppen M, Seo SW, Bowser JL, Yuan X, Li J, Sibilia M, Ambardekar AV, Zhang X, Eckle T, Yoo SH, Eltzschig HK. Transcription-independent Induction of ERBB1 through Hypoxia-inducible Factor 2A Provides Cardioprotection during Ischemia and Reperfusion. Anesthesiology. 2020 04; 132(4):763-780.
-
Koeppen M, Lee JW, Seo SW, Brodsky KS, Kreth S, Yang IV, Buttrick PM, Eckle T, Eltzschig HK. Hypoxia-inducible factor 2-alpha-dependent induction of amphiregulin dampens myocardial ischemia-reperfusion injury. Nat Commun. 2018 02 26; 9(1):816.
-
Holland NA, Fraiser CR, Sloan RC, Devlin RB, Brown DA, Wingard CJ. Ultrafine Particulate Matter Increases Cardiac Ischemia/Reperfusion Injury via Mitochondrial Permeability Transition Pore. Cardiovasc Toxicol. 2017 10; 17(4):441-450.
-
Valle Raleigh J, Mauro AG, Devarakonda T, Marchetti C, He J, Kim E, Filippone S, Das A, Toldo S, Abbate A, Salloum FN. Reperfusion therapy with recombinant human relaxin-2 (Serelaxin) attenuates myocardial infarct size and NLRP3 inflammasome following ischemia/reperfusion injury via eNOS-dependent mechanism. Cardiovasc Res. 2017 May 01; 113(6):609-619.
-
Mauro AG, Mezzaroma E, Marchetti C, Narayan P, Del Buono MG, Capuano M, Prestamburgo A, Catapano S, Salloum FN, Abbate A, Toldo S. A Preclinical Translational Study of the Cardioprotective Effects of Plasma-Derived Alpha-1 Anti-trypsin in Acute Myocardial Infarction. J Cardiovasc Pharmacol. 2017 May; 69(5):273-278.
-
Dai W, Cheung E, Alleman RJ, Perry JB, Allen ME, Brown DA, Kloner RA. Cardioprotective Effects of Mitochondria-Targeted Peptide SBT-20 in two Different Models of Rat Ischemia/Reperfusion. Cardiovasc Drugs Ther. 2016 Dec; 30(6):559-566.
-
Li L, Li J, Drum BM, Chen Y, Yin H, Guo X, Luckey SW, Gilbert ML, McKnight GS, Scott JD, Santana LF, Liu Q. Loss of AKAP150 promotes pathological remodelling and heart failure propensity by disrupting calcium cycling and contractile reserve. Cardiovasc Res. 2017 02; 113(2):147-159.
-
Toldo S, Mauro AG, Marchetti C, Rose SW, Mezzaroma E, Van Tassell BW, Kim S, Dinarello CA, Abbate A. Recombinant Human Alpha-1 Antitrypsin-Fc Fusion Protein Reduces Mouse Myocardial Inflammatory Injury After Ischemia-Reperfusion Independent of Elastase Inhibition. J Cardiovasc Pharmacol. 2016 Jul; 68(1):27-32.
-
Alleman RJ, Tsang AM, Ryan TE, Patteson DJ, McClung JM, Spangenburg EE, Shaikh SR, Neufer PD, Brown DA. Exercise-induced protection against reperfusion arrhythmia involves stabilization of mitochondrial energetics. . 2016 05 15; 310(10):H1360-70.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|